XL-protein GmbH

XL-protein seeks € 12 VC funding (Ser.A) for its spin-out XL-biologics to develop a PASylated CD40L-Fab until the end of clinical phase I.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Freising, BY, Deutschland
  • Currency EUR
  • Founded May 2009
  • Employees 8
  • Website xl-protein.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free